DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Ottawa Marriott Hotel

2018 年 10 月 30 日 7:00 上午 - 2018 年 10 月 31 日 3:00 下午

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting

Transformation with Collaboration

Session 6: Track B: Emerging Technologies and Therapies

Session Chair(s)

Fiona M Frappier, PhD

Fiona M Frappier, PhD

Senior Policy Analyst

Health Canada, Canada

Emerging technologies have started to disrupt whole industries and in doing so are demonstrating their role as amplifiers for solutions in health outcomes. This session will describe lessons learned in bringing novel therapies through to market. Strategic elements of technology transfer, securing intellectual property, and financing in the Canadian context will focus on overcoming the first valley of death. Key enablers and thought leaders will provide examples of emerging technology companies and spin offs they have shepherded through critical steps.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe key considerations in early-stage biotech investing
  • Identify a range of Canadian small start ups
  • List an overview of lessons learned from Canadian case studies

Speaker(s)

Siofradh  McMahon, MSc

Collaborating to Get Through the Valley(s) of Death in Regenerative Medicine

Siofradh McMahon, MSc

CCRM, Canada

Senior Manager, Clinical Translation and Regulatory affairs

Maxwell  Morgan, JD, LLM

Open Science Opportunities for Development and Commercialization of Novel Therapies

Maxwell Morgan, JD, LLM

Structural Genomics Consortium (SGC), Canada

Lead Legal & Policy Advisor

Nadine  Kolas

Regulation of Advanced Cell Therapies for Regenerative Medicine

Nadine Kolas

Health Canada, Canada

Senior Policy Analyst

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。